Alignment Healthcare (NASDAQ:ALHC) Stock Gets Price Target Reduction from JPMorgan Chase & Co.

Alignment Healthcare (NASDAQ:ALHC) had its price objective trimmed by JPMorgan Chase & Co. from $10.00 to $8.00 in a report released on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other equities research analysts have also issued reports about the stock. TD Cowen cut their target price on shares of Alignment Healthcare from $21.00 to $12.00 and set a “buy” rating on the stock in a report on Monday, October 12th. Needham & Company LLC initiated coverage on Alignment Healthcare in a research note on Wednesday, October 28th. They issued a “hold” rating on the stock. Weiss Ratings downgraded Alignment Healthcare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, October 9th. Barclays decreased their target price on shares of Alignment Healthcare from $10.00 to $9.00 and set an “equal weight” rating on the stock in a research report on Friday. Finally, Raymond James Financial reiterated an “outperform” rating on shares of Alignment Healthcare in a research note on Monday, October 12th. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $14.27.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $7.27 on Friday. The firm has a market capitalization of $1.52 billion, a PE ratio of 55.93 and a beta of 1.07. The stock has a fifty day simple moving average of $9.87 and a two-hundred day simple moving average of $16.82. Alignment Healthcare has a 52-week low of $6.01 and a 52-week high of $25.12. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.71 and a current ratio of 1.71.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, October 29th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a net margin of 0.59% and a return on equity of 12.46%. Alignment Healthcare’s quarterly revenue was up 36.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.02 EPS. On average, analysts predict that Alignment Healthcare will post 0.14 EPS for the current fiscal year.

Insider Activity

In related news, CEO John Kao sold 27,400 shares of the business’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $13.00, for a total value of $356,200.00. Following the sale, the chief executive officer directly owned 590,766 shares in the company, valued at approximately $7,679,958. The trade was a 4.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Maroney sold 122,707 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the transaction, the president directly owned 794,606 shares in the company, valued at $10,075,604.08. The trade was a 13.38% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 1,061,967 shares of company stock valued at $13,642,490. 5.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently bought and sold shares of the stock. Versant Capital Management Inc raised its stake in shares of Alignment Healthcare by 463.3% during the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after acquiring an additional 1,135 shares during the last quarter. Nykredit A S acquired a new stake in Alignment Healthcare in the 2nd quarter worth about $36,000. Signature Equity Partners LLC purchased a new stake in shares of Alignment Healthcare in the 1st quarter valued at $46,000. GAMMA Investing LLC increased its holdings in shares of Alignment Healthcare by 46.6% in the 2nd quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock valued at $80,000 after acquiring an additional 1,070 shares during the period. Finally, Transamerica Financial Advisors LLC acquired a new stake in Alignment Healthcare during the 2nd quarter valued at $149,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment reported third-quarter revenue of $1.36 billion, up 36.7% year over year and above the $1.31 billion analyst estimate. Adjusted EPS of a $0.04 loss matched consensus. Alignment Healthcare Reports Third Quarter 2026 Results
• Positive Sentiment: Management is targeting at least 20% top-line growth in 2027, supporting the company’s longer-term expansion narrative. Alignment Targets 2027 Growth
• Neutral Sentiment: Barclays reduced its price target from $10 to $9 while maintaining an “equal weight” rating, implying potential upside but limited conviction. Barclays Rating
• Negative Sentiment: Alignment lowered its 2026 adjusted EBITDA outlook to at least $100 million, signaling weaker near-term profitability and helping offset the revenue beat. Alignment EBITDA Outlook
• Negative Sentiment: CMS reduced the 2027 Star Rating for Alignment’s California HMO contract H3815 from 4.0 to 3.5 stars. The contract serves approximately 75% of membership, raising concerns about bonus eligibility, enrollment and reimbursement economics. Alignment H3815 CMS Rating Concerns
• Negative Sentiment: KeyCorp downgraded ALHC from “overweight” to “sector weight,” while multiple law firms announced investigations into possible securities-law violations. These notices are allegations and do not establish wrongdoing, but they add reputational and legal overhang. Alignment Investigation Notice

About Alignment Healthcare

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.